JPRN-UMIN000008640已完成未知
se-results surveillance of TALYMUS ophthalmic suspension 0.1% (tacrolimus) in severe allergic keratoconjunctivitis. - Use-results surveillance of TALYMUS ophthalmic suspension 0.1% (tacrolimus) in severe allergic keratoconjunctivitis.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects are ineligible to participate in this surveillance, if they: 1. Have a known hypersensitivity to tacrolimus hydrate or to any component of this drug 2. Are suffering from infectious eye disease 3. Are pregnant or may possibly be pregnant
研究者
相似试验
已完成
4 期
Post-marketing clinical study of TALYMUS ophthalmic suspension 0.1% (tacrolimus) in vernal keratoconjunctivitisVernal keratoconjunctivitisJPRN-UMIN000001262Senju Pharmaceutical Co., Ltd.50
尚未招募
不适用
A clinical case controled for the intraocular tamponade material in the vitretomy for idiopathic macular hole.Idiopathic macular holeJPRN-UMIN000006843Opthalmology Kansai Medical University50
招募中
不适用
Endophthalmitis Management StudyCTRI/2019/02/017876V Prasad Eye Institute
已完成
不适用
Evaluation of enophthalmos due to ophthalmic solution for glaucomaGlaucomaJPRN-UMIN000018596Department of Ophthalmology, Shiga University of Medical Science15
尚未招募
不适用
Examination of ophthalmic examination data for infants, school children, and studentsMyopia, hyperopia, astigmatismJPRN-UMIN000048458iigata University of Health and Welfare2,000